KYMR
Kymera Therapeutics Inc
122.10$
+3.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | +1,060.0% | +114.0% | -35.7% | +67.8% | -40.1% | -16.7% | |
| – | +302.4% | +7,427.9% | -96.1% | +24.2% | +6,251.4% | -96.1% | – | |
| – | – | +1,513.8% | +114.0% | -35.7% | +67.8% | -40.1% | -16.7% | |
| – | +110.2% | +67.1% | +120.6% | +19.9% | +15.1% | +27.1% | +31.8% | |
| – | +111.6% | +128.5% | +99.3% | +20.6% | +25.6% | +15.4% | +7.3% | |
| – | +110.4% | +78.0% | +115.8% | +20.0% | +17.3% | +26.5% | +25.9% | |
| – | – | – | – | – | – | – | – | |
| – | +187.5% | +150.0% | +52.2% | +0.6% | +11.4% | +27.0% | +0.0% | |
| – | – | – | – | – | – | – | – | |
| – | +4.9% | -3,682.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.